Evidence map›Paper›PMID 38321346›Full record

ArticleDrugs - real world outcomes2024

Causality Assessment Between Drugs and Fatal Cerebral Haemorrhage Using Electronic Medical Records: Comparative Evaluation of Disease-Specific and Conventional Methods.

Miki Ohta, Satoru Miyawaki, Shinichiroh Yokota, Makoto Yoshimoto, Tatsuya Maruyama, Daisuke Koide, Takashi Moritoyo, Nobuhito Saito

Abstract read
In one paragraph

Article in Drugs - real world outcomes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Miki OhtaClinical Research Promotion Centre, The University of Tokyo Hospital, Tokyo, Japan. mjohta@g.ecc.u-tokyo.ac.jp.ORCID http://orcid.org/0000-0002-4896-8868
Satoru MiyawakiDepartment of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-6369-3391
Shinichiroh YokotaDepartment of Healthcare Information Management, The University of Tokyo Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-2296-9846
Makoto YoshimotoClinical Research Promotion Centre, The University of Tokyo Hospital, Tokyo, Japan.
Tatsuya MaruyamaClinical Research Promotion Centre, The University of Tokyo Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-3169-0185
Daisuke KoideClinical Research Promotion Centre, The University of Tokyo Hospital, Tokyo, Japan.ORCID http://orcid.org/0000-0002-4238-0334
Takashi MoritoyoClinical Research Promotion Centre, The University of Tokyo Hospital, Tokyo, Japan.
Nobuhito SaitoDepartment of Neurosurgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.ORCID http://orcid.org/0000-0001-9756-781X

Funding

Ministry of Education, Culture, Sports, Science and Technology JP22K15335
6 · The paper itself

Abstract

introductionA new algorithm for causality assessment of drugs and fatal cerebral haemorrhage (ACAD-FCH) was published in 2021. However, its use in clinical practice has not been verified.

objectivesThis study aimed to explore the practical value of the ACAD-FCH when applying information available in clinical practice.

methodsThe medical records of patients who died at the University of Tokyo Hospital in 2020 were reviewed, and cases with intracranial haemorrhage were selected. Two evaluators independently assessed these cases using three methods (the ACAD-FCH, Naranjo algorithm, and WHO-UMC scale). The number of 'Yes', 'No', and 'No information/Do not know' responses to each question by both evaluators were summed and compared. Inter-rater reliability was evaluated for each method using agreement rates and kappa coefficients with 95% confidence intervals (CI).

resultsAmong 316 deaths, 24 cases with intracranial haemorrhage were evaluated. The proportion of ‛No information/Do not know' responses for each question was 35.6% (95% CI 31.4-40.6%) for the ACAD-FCH and 66.9% (95% CI 62.5-71.1%) for the Naranjo algorithm. The respective agreement rates and kappa coefficients were 0.917 (0.798-1.00) and 0.867 (0.675-1.00) for the ACAD-FCH, 0.708 (0.512-0.904) and 0.139 (-0.236 to 0.513) for the Naranjo algorithm, and 0.50 (0.284-0.716) and 0.326 (0.110-0.541) for the WHO-UMC scale, respectively.

conclusionOur findings suggest the utility of the ACAD-FCH when assessing death cases with intracranial haemorrhage. However, larger studies including intra-rater assessments are warranted for further validation of this algorithm.

Identifiers

PMID38321346
PMCPMC11176114

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.